PI3K/AKT signaling is well known to be implicated in tumorigenic activities in many types of cancer, and it is already reported that PHLPP1 has a tumor-suppressive role through the negative regulation of PI3K/AKT signaling. Here, PHLPP1 is linked to neoplasm.